193 related articles for article (PubMed ID: 21456015)
1. Prognostic significance of baseline positron emission tomography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemoradiotherapy.
Suzuki A; Xiao L; Hayashi Y; Macapinlac HA; Welsh J; Lin SH; Lee JH; Bhutani MS; Maru DM; Hofstetter WL; Swisher SG; Ajani JA
Cancer; 2011 Nov; 117(21):4823-33. PubMed ID: 21456015
[TBL] [Abstract][Full Text] [Related]
2. Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma.
Hong D; Lunagomez S; Kim EE; Lee JH; Bresalier RS; Swisher SG; Wu TT; Morris J; Liao Z; Komaki R; Ajani JA
Cancer; 2005 Oct; 104(8):1620-6. PubMed ID: 16118804
[TBL] [Abstract][Full Text] [Related]
3. The higher the decrease in the standardized uptake value of positron emission tomography after chemoradiation, the better the survival of patients with gastroesophageal adenocarcinoma.
Javeri H; Xiao L; Rohren E; Lee JH; Liao Z; Hofstetter W; Maru D; Bhutani MS; Swisher SG; Macapinlac H; Wang X; Ajani JA
Cancer; 2009 Nov; 115(22):5184-92. PubMed ID: 19685531
[TBL] [Abstract][Full Text] [Related]
4. Results of the baseline positron emission tomography can customize therapy of localized esophageal adenocarcinoma patients who achieve a clinical complete response after chemoradiation.
Suzuki A; Xiao L; Taketa T; Sudo K; Wadhwa R; Blum MA; Skinner H; Komaki R; Weston B; Lee JH; Bhutani MS; Rice DC; Maru DM; Erasmus J; Swisher SG; Hofstetter WL; Ajani JA
Ann Oncol; 2013 Nov; 24(11):2854-9. PubMed ID: 23994746
[TBL] [Abstract][Full Text] [Related]
5. The standardized uptake value of 18-fluorodeoxyglucose positron emission tomography after chemoradiation and clinical outcome in patients with localized gastroesophageal carcinoma.
Murthy SB; Patnana SV; Xiao L; Rohren E; Hofstetter WL; Swisher SG; Liao Z; Lee JH; Bhutani MS; Macapinlac HA; Wang X; Ajani JA
Oncology; 2010; 78(5-6):316-22. PubMed ID: 20699623
[TBL] [Abstract][Full Text] [Related]
6. Critical role of surgery in patients with gastroesophageal carcinoma with a poor prognosis after chemoradiation as defined by positron emission tomography.
Patnana SV; Murthy SB; Xiao L; Rohren E; Hofstetter WL; Swisher SG; Liao Z; Lee JH; Bhutani MS; Macapinlac HA; Wang X; Ajani JA
Cancer; 2010 Oct; 116(19):4487-94. PubMed ID: 20629031
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Pretherapeutic Tumor-to-Blood Standardized Uptake Ratio in Patients with Esophageal Carcinoma.
Bütof R; Hofheinz F; Zöphel K; Stadelmann T; Schmollack J; Jentsch C; Löck S; Kotzerke J; Baumann M; van den Hoff J
J Nucl Med; 2015 Aug; 56(8):1150-6. PubMed ID: 26089549
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of metabolic tumor volume and total lesion glycolysis in esophageal carcinoma patients treated with definitive chemoradiotherapy.
Yildirim BA; Torun N; Guler OC; Onal C
Nucl Med Commun; 2018 Jun; 39(6):553-563. PubMed ID: 29668513
[TBL] [Abstract][Full Text] [Related]
9. Prediction of response to definitive chemoradiotherapy in esophageal cancer using positron emission tomography.
Kato H; Fukuchi M; Miyazaki T; Nakajima M; Tanaka N; Inose T; Kimura H; Faried A; Saito K; Sohda M; Fukai Y; Masuda N; Manda R; Ojima H; Tsukada K; Oriuchi N; Endo K; Nonaka T; Shioya M; Ishikawa H; Sakurai H; Nakano T; Kuwano H
Anticancer Res; 2007; 27(4C):2627-33. PubMed ID: 17695425
[TBL] [Abstract][Full Text] [Related]
10. Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinoma.
Konski AA; Cheng JD; Goldberg M; Li T; Maurer A; Yu JQ; Haluszka O; Scott W; Meropol NJ; Cohen SJ; Freedman G; Weiner LM
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):358-63. PubMed ID: 17532577
[TBL] [Abstract][Full Text] [Related]
11. Prediction of outcome with FDG-PET in definitive chemoradiotherapy for esophageal cancer.
Atsumi K; Nakamura K; Abe K; Hirakawa M; Shioyama Y; Sasaki T; Baba S; Isoda T; Ohga S; Yoshitake T; Shinoto M; Asai K; Honda H
J Radiat Res; 2013 Sep; 54(5):890-8. PubMed ID: 23520267
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of patients with esophageal cancer staged with [¹⁸F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility of resection?
Monjazeb AM; Riedlinger G; Aklilu M; Geisinger KR; Mishra G; Isom S; Clark P; Levine EA; Blackstock AW
J Clin Oncol; 2010 Nov; 28(31):4714-21. PubMed ID: 20876421
[TBL] [Abstract][Full Text] [Related]
13. Postchemoradiotherapy positron emission tomography predicts pathologic response and survival in patients with esophageal cancer.
Jayachandran P; Pai RK; Quon A; Graves E; Krakow TE; La T; Loo BW; Koong AC; Chang DT
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):471-7. PubMed ID: 22381904
[TBL] [Abstract][Full Text] [Related]
14. Favorable versus unfavorable prognostic groups by post-chemoradiation FDG-PET imaging in node-positive esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy.
Yap WK; Chang YC; Hsieh CH; Chao YK; Chen CC; Shih MC; Hung TM
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):689-698. PubMed ID: 29188300
[TBL] [Abstract][Full Text] [Related]
15. Nomograms for prognostication of outcome in patients with esophageal and gastroesophageal carcinoma undergoing definitive chemoradiotherapy.
Suzuki A; Xiao L; Hayashi Y; Blum MA; Welsh JW; Lin SH; Lee JH; Bhutani MS; Weston B; Maru DM; Rice DC; Swisher SG; Hofstetter WL; Erasmus J; Ajani JA
Oncology; 2012; 82(2):108-13. PubMed ID: 22328056
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
17. Confirmation of the prognostic value of pretherapeutic tumor SUR and MTV in patients with esophageal squamous cell carcinoma.
Hofheinz F; Li Y; Steffen IG; Lin Q; Lili C; Hua W; van den Hoff J; Zschaeck S
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1485-1494. PubMed ID: 30949816
[TBL] [Abstract][Full Text] [Related]
18. Assessment of tumor response to definitive chemoradiotherapy and prognosis prediction in patients with esophageal cancer judged by PET response criteria in solid tumors: multicenter study in Japan.
Kitajima K; Kaida H; Nakatani K; Ishibashi M; Morita T; Nakajo M; Tamaki Y; Minamimoto R
Nucl Med Commun; 2020 May; 41(5):443-451. PubMed ID: 32187159
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of metabolic response measured by 18F-FDG-PET in oesophageal cancer patients treated with definitive chemoradiotherapy.
Onal C; Torun N; Guler OC; Yildirim BA
Nucl Med Commun; 2016 Dec; 37(12):1282-1289. PubMed ID: 27612030
[TBL] [Abstract][Full Text] [Related]
20. Locally advanced esophageal adenocarcinoma: response to neoadjuvant chemotherapy and survival predicted by ([18F])FDG-PET/CT.
Kauppi JT; Oksala N; Salo JA; Helin H; Karhumäki L; Kemppainen J; Sihvo EI; Räsänen JV
Acta Oncol; 2012 May; 51(5):636-44. PubMed ID: 22208782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
